Financials
Financial year 2025
WEST PHARMA from Anderlecht, company number BE0629726275, closed financial year 2025 with a result of € 51,399 after tax. For that financial year WEST PHARMA recorded a gross margin of € 189,693 and equity of € 284,177. Compared with financial year 2024, the result moved from € 14,395 to € 51,399. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 284,177
▲ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 51,399
▲ 257% vs 2024
Profit after tax over the fiscal year.
€ 77,725
▼ 13% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 265,577.
People and assets in 2025
3.1
Average over the fiscal year, from the social balance sheet.
€ 89,747
▲ 2% vs 2024
€ 29,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 160,065
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 152,631
▲ € 120,558 vs 2024
€ 34,459 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 166,899
▲ 82% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 30,541
▲ 6% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 275,335 | € 167,662 | € 124,686 | € 189,693 | ▲ 52% |
| Profit after taxes | € 158,445 | € 59,018 | € 14,395 | € 51,399 | ▲ 257% |
| Equity | € 263,193 | € 322,211 | € 232,778 | € 284,177 | ▲ 22% |
| Total debts | € 256,642 | € 249,985 | € 269,235 | € 417,472 | ▲ 55% |
| Cash | € 55,262 | € 85,115 | € 89,151 | € 77,725 | ▼ 13% |
| Retained profit | € 244,593 | € 303,611 | € 214,178 | € 265,577 | ▲ 24% |
| Dividend | € 0 | € 0 | € 103,828 | € 0 | ▼ 100% |
| Bank debt | € 106,897 | € 83,695 | € 32,073 | € 152,631 | ▲ € 120,558 |
| Balance sheet total | € 519,836 | € 572,196 | € 502,013 | € 701,649 | ▲ 40% |
| Employees (FTE) | 2.2 | 2.7 | 3.1 | 3.1 |
Key figures of WEST PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to WEST PHARMA?
What happened at WEST PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 51,399 (▲ 257% vs 2024). filed late Source: NBB ↗
- New establishment in Anderlecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 158,445 profit in 2022 to € 51,399 profit in 2025.
Paid € 86,830 in corporate taxes since 2022.
Best year ever: 2022, with € 158,445 profit.
On average € 61,200 of value added per employee in 2025.
A new publication or filing at WEST PHARMA? We notify you, reason included.
Follow WEST PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind WEST PHARMA are YUNUS BAKAR and Metin Bakar. The same people are also behind BKR. Metin Bakar is also behind PHARMABAK, B&B PHARMA, "WESTLAND PHARMA" and Pharma City 2.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Sylvain Dupuislaan 310
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0629.726.275
- VAT number
- BE 0629.726.275
- Registered office
- Sylvain Dupuislaan 310, 1070 Anderlecht
- Names & denominations
- WEST PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 May 2015
- Peppol
- Active · Active since 6 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten